Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algeron vs PegIntron in Chronic Hepatitis C
NCT01740089Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Nov 2011
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ropeginterferon alfa-2b in hepatitis C (HCV), sponsored by BIOCAD. Started Nov 2011; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01740089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740089.